Belinda Jackson Njiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Belinda Jackson Njiro has a total of 263 co-authors. Here are the top co-authors by number of shared publications:
- Harrieth Peter Ndumwa
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
13 shared publications - Bruno Fokas Sunguya
Department of Community Health, Muhimbili University of Health and Allied Sciences, United Nations Road, Upanga, Dar es Salaam, Tanzania
12 shared publications - Jackline E. Ngowi
Muhimbili University of Health and Allied Sciences
10 shared publications - George Msema Bwire
Department of Pharmaceutical Microbiology Muhimbili University of Health and Allied Sciences Dar es Salaam Tanzania
9 shared publications - James Tumaini Kengia
President’s Office Regional Administration and Local Government, P O Box 1923 Dodoma, Tanzania
9 shared publications - Castory Munishi
Pharm R&D Lab and Department of Medicinal Chemistry, School of Pharmacy, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania
8 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1004977
Impact of violence on HIV outcomes among female sex workers: A global systematic review and meta-analysis
Background: Female sex workers (FSW) are a key population for HIV prevention and care. Increasing evidence suggests that social and structural barriers are key drivers of HIV transmission. This global systematic review assesses whether experiencing violence is associated with worse HIV outcomes among FSW. Methods and findings: We searched MEDLINE, Embase, and PsycINFO databases for studies published from January 1st, 2010 to June 9th, 2026 assessing the impact of violence on HIV outcomes among FSW, without restriction to language and study design. Some studies had multiple estimates due to reporting on multiple outcomes or exposures of interest. We pooled data from eligible studies using multi-level random-effects meta-analyses to quantify associations between recent (past year) or lifetime exposure to violence (physical, sexual, emotional/psychological, and/or financial) and HIV outcomes (prevalent and incident HIV infection, HIV testing, ART use, ART adherence, and viral suppression) among FSW. We preferentially used adjusted estimates over unadjusted estimates if both were available. We included 94 studies with 226 estimates, comprising 186,613 FSWs in 39 countries. Half the included studies were in low- and middle-income countries ( n = 47, 50%), and one-fifth were in low-income countries ( n = 18; 19%). We found higher odds of prevalent HIV infection among FSWs with recent (pooled odds ratio (pOR):1.31; 95% CI [1.16,1.48]; I 2 : 63%; n = 75 estimates) and lifetime (pOR:1.35; 95% CI [1.23,1.48]; I 2 : 39%; n = 68) experiences of violence. When stratifying violence by type, we found the strongest pooled associations between recent (pOR:1.55; 95% CI [1.24,1.94]; I 2 : 69%; n = 28) and lifetime (pOR:1.40; 95% CI [1.21,1.63]; I 2 : 47%; n = 28) experiences of sexual violence and HIV prevalence. Recently experiencing violence was associated with reduced odds of ART use (pOR:0.78; 95% CI [0.64,0.94]; I 2 : 8%; n = 17). Lifetime exposure to violence was associated with reduced odds of viral suppression (pOR:0.88; 95% CI [0.79,0.98]; I 2 : 20%; n = 6). There was no evidence of associations between violence and HIV incidence, HIV testing, and ART adherence. Our study had limitations, notably the cross-sectional design of most included studies, the heterogeneity in pooled estimates, and the difficulties of measuring experiences of violence. Conclusions: Experiencing violence is associated with greater odds of prevalent HIV infections, and poorer HIV treatment outcomes among FSWs. HIV interventions for FSWs must address violence as a structural determinant of HIV.
- 21 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1004977
Open AccessImpact of violence on HIV outcomes among female sex workers: A global systematic review and meta-analysis
Background: Female sex workers (FSW) are a key population for HIV prevention and care. Increasing evidence suggests that social and structural barriers are key drivers of HIV transmission. This global systematic review assesses whether experiencing violence is associated with worse HIV outcomes among FSW. Methods and findings: We searched MEDLINE, Embase, and PsycINFO databases for studies published from January 1st, 2010 to June 9th, 2026 assessing the impact of violence on HIV outcomes among FSW, without restriction to language and study design. Some studies had multiple estimates due to reporting on multiple outcomes or exposures of interest. We pooled data from eligible studies using multi-level random-effects meta-analyses to quantify associations between recent (past year) or lifetime exposure to violence (physical, sexual, emotional/psychological, and/or financial) and HIV outcomes (prevalent and incident HIV infection, HIV testing, ART use, ART adherence, and viral suppression) among FSW. We preferentially used adjusted estimates over unadjusted estimates if both were available. We included 94 studies with 226 estimates, comprising 186,613 FSWs in 39 countries. Half the included studies were in low- and middle-income countries ( n = 47, 50%), and one-fifth were in low-income countries ( n = 18; 19%). We found higher odds of prevalent HIV infection among FSWs with recent (pooled odds ratio (pOR):1.31; 95% CI [1.16,1.48]; I 2 : 63%; n = 75 estimates) and lifetime (pOR:1.35; 95% CI [1.23,1.48]; I 2 : 39%; n = 68) experiences of violence. When stratifying violence by type, we found the strongest pooled associations between recent (pOR:1.55; 95% CI [1.24,1.94]; I 2 : 69%; n = 28) and lifetime (pOR:1.40; 95% CI [1.21,1.63]; I 2 : 47%; n = 28) experiences of sexual violence and HIV prevalence. Recently experiencing violence was associated with reduced odds of ART use (pOR:0.78; 95% CI [0.64,0.94]; I 2 : 8%; n = 17). Lifetime exposure to violence was associated with reduced odds of viral suppression (pOR:0.88; 95% CI [0.79,0.98]; I 2 : 20%; n = 6). There was no evidence of associations between violence and HIV incidence, HIV testing, and ART adherence. Our study had limitations, notably the cross-sectional design of most included studies, the heterogeneity in pooled estimates, and the difficulties of measuring experiences of violence. Conclusions: Experiencing violence is associated with greater odds of prevalent HIV infections, and poorer HIV treatment outcomes among FSWs. HIV interventions for FSWs must address violence as a structural determinant of HIV.
- 18 October 2026
- Published by Wiley in HIV Medicine
Antiretroviral therapy intensification in people living with HIV on virological and clinical outcomes: A systematic review
Background: Antiretroviral therapy (ART) intensification involves increasing the dose or frequency of existing regimens or adding agents to standard therapy. This systematic review evaluated the impact of ART intensification on selected virological and clinical outcomes among people living with HIV. Methods: We searched PubMed/MEDLINE, Embase, and Scopus for English‐language studies published from database inception to 5 July 2024. Risk of bias was assessed using Cochrane tools. This review was registered by PROSPERO registration: CRD42024565822. Results: Of 1652 identified records, 22 studies met the inclusion criteria. Virological outcomes were heterogeneous, with most strategies showing no significant improvement in viral suppression or HIV reservoir reduction. Neurocognitive outcomes were inconsistent, while immune recovery was observed in some studies. ART intensification was generally safe and well tolerated, although evidence on long‐term outcomes remains limited. Conclusions: There was no consistent evidence supporting a clear benefit of ART intensification on virological or clinical outcomes. ART intensification outcomes vary according to drug selection, patient characteristics, and treatment goals. These findings highlight the uncertainty surrounding the clinical utility of ART intensification. Further research is needed to optimize intensification strategies for specific patient populations and to better define its role in long‐term HIV management.
- 18 October 2026
- Published by Wiley in HIV Medicine
Antiretroviral therapy intensification in people living with HIV on virological and clinical outcomes: A systematic review
Background: Antiretroviral therapy (ART) intensification involves increasing the dose or frequency of existing regimens or adding agents to standard therapy. This systematic review evaluated the impact of ART intensification on selected virological and clinical outcomes among people living with HIV. Methods: We searched PubMed/MEDLINE, Embase, and Scopus for English‐language studies published from database inception to 5 July 2024. Risk of bias was assessed using Cochrane tools. This review was registered by PROSPERO registration: CRD42024565822. Results: Of 1652 identified records, 22 studies met the inclusion criteria. Virological outcomes were heterogeneous, with most strategies showing no significant improvement in viral suppression or HIV reservoir reduction. Neurocognitive outcomes were inconsistent, while immune recovery was observed in some studies. ART intensification was generally safe and well tolerated, although evidence on long‐term outcomes remains limited. Conclusions: There was no consistent evidence supporting a clear benefit of ART intensification on virological or clinical outcomes. ART intensification outcomes vary according to drug selection, patient characteristics, and treatment goals. These findings highlight the uncertainty surrounding the clinical utility of ART intensification. Further research is needed to optimize intensification strategies for specific patient populations and to better define its role in long‐term HIV management.
- Open Access
- 8 October 2026
- Published by MDPI AG in Preprints.org
Demand Promotion Interventions to Improve COVID-19 Vaccine Uptake: A Systematic Review of the Global Evidence
Background/Objectives: The global rollout of COVID-19 vaccines faced significant implementation challenges: limited adult immunization infrastructure, particularly in low- and middle-income countries; rapidly shifting viral epidemiology driven by emerging variants; and widespread vaccine misinformation that fueled hesitancy. Achieving the high coverage necessary to curb transmission required urgent attention to demand-side barriers, making the identification of effective interventions a critical public health priority. This systematic review synthesized global evidence on communication, behavioral, and health systems interventions to increase COVID-19 vaccine demand and uptake. The review assessed intervention effectiveness across diverse population groups and settings and identified lessons to inform the design of adult vaccination programs and future outbreak response. Methods: Between March 2022 and July 2024, we performed a systematic search in PubMed, Scopus, and Global Index Medicus, for COVID-19 demand and uptake studies published after December 2020, with no language or geographic restrictions. Eligible papers were those that reported intervention studies with quantitative comparative outcomes on vaccination attitudes, appointment rates, uptake, or coverage following an intervention. Study quality was assessed using adapted Critical Appraisal Skills Program (CASP) criteria. Studies were categorized into nine intervention approaches, based on an adapted communication and service-delivery taxonomy. Interventions operated at individual, systems, and structural levels. A narrative synthesis was combined with vote counting of studies with positive findings to understand what intervention approaches were effective. and under what conditions. Results: From over 23,000 records, 57 studies from 27 countries met inclusion and quality criteria. Most studies were conducted in high-income countries. Overall, 70% of studies reported positive findings on at least one vaccination outcome. Educational interventions were the most frequently studied approach and were most effective when delivered through multiple channels by trusted messengers and integrated with complementary strategies, rather than as standalone information provision. Reminder and nudge interventions showed mixed results, performing best when embedded within multicomponent approaches that addressed both logistical and attitudinal barriers. Access-enhancing and service delivery interventions demonstrated the most consistent evidence of effectiveness, with nine of ten studies reporting positive outcomes; successful approaches included on-site vaccination, mobile units, pharmacy and community health worker delivery, and integration into existing healthcare touchpoints. Vaccine mandates demonstrated the strongest and most consistent effects on coverage at scale, though their coercive mechanism raises ethical considerations around autonomy, equity, and public trust. Conclusions: Improving COVID-19 vaccine uptake requires interventions that simultaneously address knowledge gaps, practical barriers to access, and structural determinants of vaccination behavior. The most effective strategies combined educational, behavioral, and service delivery components tailored to the needs and barriers of specific groups. Policymakers should prioritize access-enhancing and systems-strengthening interventions as a foundation, supplement these with targeted communication delivered by trusted messengers, and reserve mandate-based approaches for situations where less restrictive measures have proven insufficient. These findings have relevance beyond COVID-19, offering transferable lessons for adult immunization programs and future outbreak preparedness.
- 8 October 2026
- Published by MDPI AG in Preprints.org
Open AccessDemand Promotion Interventions to Improve COVID-19 Vaccine Uptake: A Systematic Review of the Global Evidence
Background/Objectives: The global rollout of COVID-19 vaccines faced significant implementation challenges: limited adult immunization infrastructure, particularly in low- and middle-income countries; rapidly shifting viral epidemiology driven by emerging variants; and widespread vaccine misinformation that fueled hesitancy. Achieving the high coverage necessary to curb transmission required urgent attention to demand-side barriers, making the identification of effective interventions a critical public health priority. This systematic review synthesized global evidence on communication, behavioral, and health systems interventions to increase COVID-19 vaccine demand and uptake. The review assessed intervention effectiveness across diverse population groups and settings and identified lessons to inform the design of adult vaccination programs and future outbreak response. Methods: Between March 2022 and July 2024, we performed a systematic search in PubMed, Scopus, and Global Index Medicus, for COVID-19 demand and uptake studies published after December 2020, with no language or geographic restrictions. Eligible papers were those that reported intervention studies with quantitative comparative outcomes on vaccination attitudes, appointment rates, uptake, or coverage following an intervention. Study quality was assessed using adapted Critical Appraisal Skills Program (CASP) criteria. Studies were categorized into nine intervention approaches, based on an adapted communication and service-delivery taxonomy. Interventions operated at individual, systems, and structural levels. A narrative synthesis was combined with vote counting of studies with positive findings to understand what intervention approaches were effective. and under what conditions. Results: From over 23,000 records, 57 studies from 27 countries met inclusion and quality criteria. Most studies were conducted in high-income countries. Overall, 70% of studies reported positive findings on at least one vaccination outcome. Educational interventions were the most frequently studied approach and were most effective when delivered through multiple channels by trusted messengers and integrated with complementary strategies, rather than as standalone information provision. Reminder and nudge interventions showed mixed results, performing best when embedded within multicomponent approaches that addressed both logistical and attitudinal barriers. Access-enhancing and service delivery interventions demonstrated the most consistent evidence of effectiveness, with nine of ten studies reporting positive outcomes; successful approaches included on-site vaccination, mobile units, pharmacy and community health worker delivery, and integration into existing healthcare touchpoints. Vaccine mandates demonstrated the strongest and most consistent effects on coverage at scale, though their coercive mechanism raises ethical considerations around autonomy, equity, and public trust. Conclusions: Improving COVID-19 vaccine uptake requires interventions that simultaneously address knowledge gaps, practical barriers to access, and structural determinants of vaccination behavior. The most effective strategies combined educational, behavioral, and service delivery components tailored to the needs and barriers of specific groups. Policymakers should prioritize access-enhancing and systems-strengthening interventions as a foundation, supplement these with targeted communication delivered by trusted messengers, and reserve mandate-based approaches for situations where less restrictive measures have proven insufficient. These findings have relevance beyond COVID-19, offering transferable lessons for adult immunization programs and future outbreak preparedness.
- Open Access
The Long-Term Outcomes of Neural Tube Defects in Eastern Africa: A Systematic Review and Meta-Analysis
Background: Neural tube defects (NTDs) are preventable congenital malformations that disproportionately affect low and middle-income countries and contribute to disability and mortality. Evidence on the long-term outcomes of children and adolescents with NTDs in Eastern Africa has not been comprehensively synthesised. We conducted a systematic review and meta-analysis to assess survival, complications, and functional outcomes among children with NTDs in this region. Methods: We searched PubMed, MEDLINE (Ovid), Cochrane Library, Web of Science, and Africa Index Medicus from the earliest records to April 2025. Two reviewers independently screened studies, assessed quality, and extracted data. We included studies reporting outcomes beyond one year of age, except mortality, which was assessed from birth onwards. Random-effects meta-analyses were undertaken when at least two sufficiently studies were available; otherwise, findings were synthesised narratively. Results: Of 597 articles screened, 16 studies involving 2,340 children with NTDs met the inclusion criteria. Pooled cumulative mortality was 23% (95% CI: 12–36%) in the neonatal period, 9% (95% CI: 2–33%) during infancy, 22% (95% CI: 16–28%) in toddlers, 37% (95% CI: 30–44%) in pre-school-aged children and 45% (95% CI: 36–54%) in school-aged children. The pooled prevalence of hydrocephalus was 41% (95% CI: 34–48%) with little variation by age. Neurogenic bladder increased from 53% (95% CI 49-81%) in toddlers to 83% (95 % CI 72-91%) in adolescents, while impaired mobility affected about 61% (95% CI 48-72%) of adolescents. School enrolment was 53% (95% CI: 39-67%), with 9% (95% CI: 4%–19%) in specialized education. Speech, hearing, and bowel dysfunction were understudied (≤ 2 studies each). Conclusion: Many children with NTDs in the Eastern African region survive beyond infancy but frequently experience hydrocephalus, neurogenic bladder and motor impairment. Longitudinal studies, context-specific guidelines, and follow-up systems are urgently needed to improve care and long-term outcomes. PROSPERO registered number: CRD420251019868 What is already known on this topic: NTDs carry a substantial burden of mortality and lifelong disability. Survival and long-term outcomes in high-income settings are well-documented, but evidence from the Eastern African region is limited and fragmented. Existing studies provide an incomplete picture of survival, complications, functional outcomes, and school participation beyond infancy What this study adds: This review demonstrates that mortality among children with NTDs increases substantially throughout childhood. Hydrocephalus, neurogenic bladder, impaired mobility, and low school enrolment are common, while bowel, speech, and hearing outcomes remain poorly reported. How this study might affect research practise or policy: These findings underscore the need for structured long-term follow-up and multidisciplinary care for children with NTDs encompassing rehabilitation, continence care, and inclusive education. Future research should prioritise prospective cohort designs with standardised outcome measurement to generate context-specific evidence
Open AccessThe Long-Term Outcomes of Neural Tube Defects in Eastern Africa: A Systematic Review and Meta-Analysis
Background: Neural tube defects (NTDs) are preventable congenital malformations that disproportionately affect low and middle-income countries and contribute to disability and mortality. Evidence on the long-term outcomes of children and adolescents with NTDs in Eastern Africa has not been comprehensively synthesised. We conducted a systematic review and meta-analysis to assess survival, complications, and functional outcomes among children with NTDs in this region. Methods: We searched PubMed, MEDLINE (Ovid), Cochrane Library, Web of Science, and Africa Index Medicus from the earliest records to April 2025. Two reviewers independently screened studies, assessed quality, and extracted data. We included studies reporting outcomes beyond one year of age, except mortality, which was assessed from birth onwards. Random-effects meta-analyses were undertaken when at least two sufficiently studies were available; otherwise, findings were synthesised narratively. Results: Of 597 articles screened, 16 studies involving 2,340 children with NTDs met the inclusion criteria. Pooled cumulative mortality was 23% (95% CI: 12–36%) in the neonatal period, 9% (95% CI: 2–33%) during infancy, 22% (95% CI: 16–28%) in toddlers, 37% (95% CI: 30–44%) in pre-school-aged children and 45% (95% CI: 36–54%) in school-aged children. The pooled prevalence of hydrocephalus was 41% (95% CI: 34–48%) with little variation by age. Neurogenic bladder increased from 53% (95% CI 49-81%) in toddlers to 83% (95 % CI 72-91%) in adolescents, while impaired mobility affected about 61% (95% CI 48-72%) of adolescents. School enrolment was 53% (95% CI: 39-67%), with 9% (95% CI: 4%–19%) in specialized education. Speech, hearing, and bowel dysfunction were understudied (≤ 2 studies each). Conclusion: Many children with NTDs in the Eastern African region survive beyond infancy but frequently experience hydrocephalus, neurogenic bladder and motor impairment. Longitudinal studies, context-specific guidelines, and follow-up systems are urgently needed to improve care and long-term outcomes. PROSPERO registered number: CRD420251019868 What is already known on this topic: NTDs carry a substantial burden of mortality and lifelong disability. Survival and long-term outcomes in high-income settings are well-documented, but evidence from the Eastern African region is limited and fragmented. Existing studies provide an incomplete picture of survival, complications, functional outcomes, and school participation beyond infancy What this study adds: This review demonstrates that mortality among children with NTDs increases substantially throughout childhood. Hydrocephalus, neurogenic bladder, impaired mobility, and low school enrolment are common, while bowel, speech, and hearing outcomes remain poorly reported. How this study might affect research practise or policy: These findings underscore the need for structured long-term follow-up and multidisciplinary care for children with NTDs encompassing rehabilitation, continence care, and inclusive education. Future research should prioritise prospective cohort designs with standardised outcome measurement to generate context-specific evidence
- Open Access
- 1 June 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (6)
Overall and cause-specific mortality and associated risk factors among middle-aged and older South Africans: findings from the health and ageing in Africa: a longitudinal study of an INDEPTH community in rural South Africa (HAALSI)
Background: Assessing mortality levels, causes of death and associated risk factors is critical for strengthening health systems and guiding targeted health interventions. We examined overall and cause-specific mortality and their associated risk factors among middle-aged and older adults in a rural, rapidly transitioning South African setting. Methods: Data were drawn from the Health and Ageing in Africa: A Longitudinal Study of an INDEPTH Community (HAALSI) cohort. Risk factors for mortality from 2014/2015 to 2021 were analysed using Cox-Proportional Hazards and Fine and Gray competing-risk models. Results: The 5059 adults aged 40 years and older at enrolment in the HAALSI cohort in 2014/2015 experienced 1116 (22.1%) deaths over 28 955 person-years of follow-up by 2021. Overall, mortality was higher in men (48.3 deaths per 1000 person-years) than women (30.7 deaths per 1000 person-years). Risk of death increased with age and was significantly associated with male sex, lower education, history of smoking or alcohol use, poor self-rated health, underweight, limitations in activities of daily living, slower walk speed, lower grip strength and histories of hypertension, diabetes, stroke, tuberculosis and unsuppressed Human Immunodeficiency Virus (HIV) infection. Cardiovascular diseases were the leading causes of death (30.3%) in both men (25.9%) and women (35.8%), followed by other infectious diseases (23.8%), neoplasms (14.4%), HIV/AIDS and tuberculosis (10.1%). Conclusion: These findings highlight the dual mortality burden from non-communicable and infectious diseases among older adults in rural South Africa. Integrated interventions targeting non-communicable diseases, infectious diseases and physical function are urgently needed to reduce premature mortality and improve health outcomes.
- 1 June 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (6)
Open AccessOverall and cause-specific mortality and associated risk factors among middle-aged and older South Africans: findings from the health and ageing in Africa: a longitudinal study of an INDEPTH community in rural South Africa (HAALSI)
Background: Assessing mortality levels, causes of death and associated risk factors is critical for strengthening health systems and guiding targeted health interventions. We examined overall and cause-specific mortality and their associated risk factors among middle-aged and older adults in a rural, rapidly transitioning South African setting. Methods: Data were drawn from the Health and Ageing in Africa: A Longitudinal Study of an INDEPTH Community (HAALSI) cohort. Risk factors for mortality from 2014/2015 to 2021 were analysed using Cox-Proportional Hazards and Fine and Gray competing-risk models. Results: The 5059 adults aged 40 years and older at enrolment in the HAALSI cohort in 2014/2015 experienced 1116 (22.1%) deaths over 28 955 person-years of follow-up by 2021. Overall, mortality was higher in men (48.3 deaths per 1000 person-years) than women (30.7 deaths per 1000 person-years). Risk of death increased with age and was significantly associated with male sex, lower education, history of smoking or alcohol use, poor self-rated health, underweight, limitations in activities of daily living, slower walk speed, lower grip strength and histories of hypertension, diabetes, stroke, tuberculosis and unsuppressed Human Immunodeficiency Virus (HIV) infection. Cardiovascular diseases were the leading causes of death (30.3%) in both men (25.9%) and women (35.8%), followed by other infectious diseases (23.8%), neoplasms (14.4%), HIV/AIDS and tuberculosis (10.1%). Conclusion: These findings highlight the dual mortality burden from non-communicable and infectious diseases among older adults in rural South Africa. Integrated interventions targeting non-communicable diseases, infectious diseases and physical function are urgently needed to reduce premature mortality and improve health outcomes.
- 25 March 2026
- Published by Ankara University in European Annals of Dental Sciences
- Vol. 53 (1) , 29-34
Oral Health-Related Quality of Life In The Initial Phase of Orthodontic Treatment in a Tanzanian Population
Objective: This study aimed to explore oral health-related quality of life (OHRQoL) among patients during first month of orthodontic treatment in Tanzania. Materials and Methods: The study involved 178 patients seeking orthodontic treatment at the MUHAS Dental Clinic. Participants aged 12 - 40 years were conveniently selected and followed up for one month after orthodontic treatment. The Oral Health Impact Profile (OHIP-14) questionnaire was used to collect data on OHRQoL. Descriptive and bivariate analyses used Mann-Whitney U, Chi-square, and McNemar tests. Multivariate logistic regression analysis was used to determine independent predictors of OHRQoL. Results: Nearly all participants (95.5%) experienced pain during orthodontic treatment. Physical pain, such as "painful aching" and "uncomfortable eating," worsened one-month post-treatment (p<0.01). Participants aged 20-39 reported a greater impact on quality of life, reflected by higher OHIP-14 scores. Social disability improved, with fewer reports of irritability and difficulties in daily tasks (p<0.05). Pain was a single independent factor significantly associated with OHRQoL changes in this study, where higher pain scores were significantly associated with worse quality of life reported (aOR=1.21; 95%CI: 1.066, 1.373); p=0.003). Conclusion: Most participants experienced increased physical discomfort, including pain and difficulties with eating, during the first month of fixed orthodontic treatment. Older patients had significantly higher OHIP-14 scores. Our findings underscore the need for focused pain management and psychosocial support during early treatment. We recommend providing comprehensive support to address physical and psychological challenges to optimize patient experience and outcomes during orthodontic care.
- 25 March 2026
- Published by Ankara University in European Annals of Dental Sciences
- Vol. 53 (1) , 29-34
Oral Health-Related Quality of Life In The Initial Phase of Orthodontic Treatment in a Tanzanian Population
Objective: This study aimed to explore oral health-related quality of life (OHRQoL) among patients during first month of orthodontic treatment in Tanzania. Materials and Methods: The study involved 178 patients seeking orthodontic treatment at the MUHAS Dental Clinic. Participants aged 12 - 40 years were conveniently selected and followed up for one month after orthodontic treatment. The Oral Health Impact Profile (OHIP-14) questionnaire was used to collect data on OHRQoL. Descriptive and bivariate analyses used Mann-Whitney U, Chi-square, and McNemar tests. Multivariate logistic regression analysis was used to determine independent predictors of OHRQoL. Results: Nearly all participants (95.5%) experienced pain during orthodontic treatment. Physical pain, such as "painful aching" and "uncomfortable eating," worsened one-month post-treatment (p<0.01). Participants aged 20-39 reported a greater impact on quality of life, reflected by higher OHIP-14 scores. Social disability improved, with fewer reports of irritability and difficulties in daily tasks (p<0.05). Pain was a single independent factor significantly associated with OHRQoL changes in this study, where higher pain scores were significantly associated with worse quality of life reported (aOR=1.21; 95%CI: 1.066, 1.373); p=0.003). Conclusion: Most participants experienced increased physical discomfort, including pain and difficulties with eating, during the first month of fixed orthodontic treatment. Older patients had significantly higher OHIP-14 scores. Our findings underscore the need for focused pain management and psychosocial support during early treatment. We recommend providing comprehensive support to address physical and psychological challenges to optimize patient experience and outcomes during orthodontic care.
- Open Access
- 13 March 2026
- Published by Elsevier in Public Health
- Vol. 254, 106246
Clustering of cardiovascular risk factors and their association with socio-demographic and lifestyle factors in middle-aged and older adults in rural northeast South Africa: Findings from HAALSI
- 13 March 2026
- Published by Elsevier in Public Health
- Vol. 254, 106246
Open AccessClustering of cardiovascular risk factors and their association with socio-demographic and lifestyle factors in middle-aged and older adults in rural northeast South Africa: Findings from HAALSI
- Open Access
- 10 March 2026
- Published by Springer Nature in AIDS and Behavior
- Vol. 30 (10) , 1-10
Alcohol Use, Risky Alcohol Use, and Associated Factors Among Adults Living with HIV in Urban Dar es Salaam, Tanzania
Alcohol use and risky alcohol use are associated with health, social, and psychological complications and may interfere with HIV/AIDS treatment. This study assessed the prevalence and factors associated with alcohol use and risky alcohol use among adults living with HIV in Dar-es-Salaam, Tanzania. This cross-sectional study included data from 771 adults living with HIV on antiretroviral therapy (ART) who were enrolled in a non-inferiority cluster randomized controlled trial. Alcohol use and risky drinking in the past 12 months were assessed using the Alcohol Use Disorders Identification Test (AUDIT-C) tool. Log-binomial regression models were applied to identify factors associated with alcohol use and risky alcohol use. Overall, 31.4% of participants reported current alcohol use ( n = 242). Among these individuals, 45.5% ( n = 110) engaged in risky alcohol use (14.2% among all participants). About a quarter (23.2%) were classified as engaging in heavy episodic drinking (HED). In multivariable models, older adults (RR = 0.27; 95%CI: 0.13–0.54) and males (RR = 0.68; 95%CI: 0.46–1.01) had a lower risk of risky alcohol use. Individuals who had disclosed their status to their partners were more likely to report risky alcohol use compared to those who had not disclosed (RR = 1.33; 95%CI:1.00–1.78). These findings indicate that alcohol use is common among adults living with HIV, with half of current drinkers engaging in risky consumption patterns, including HED. Risky alcohol use was more prevalent among younger adults and women. These results underscore the need for targeted interventions addressing risky alcohol use within primary HIV care settings, particularly for young adults and women.
- 10 March 2026
- Published by Springer Nature in AIDS and Behavior
- Vol. 30 (10) , 1-10
Open AccessAlcohol Use, Risky Alcohol Use, and Associated Factors Among Adults Living with HIV in Urban Dar es Salaam, Tanzania
Alcohol use and risky alcohol use are associated with health, social, and psychological complications and may interfere with HIV/AIDS treatment. This study assessed the prevalence and factors associated with alcohol use and risky alcohol use among adults living with HIV in Dar-es-Salaam, Tanzania. This cross-sectional study included data from 771 adults living with HIV on antiretroviral therapy (ART) who were enrolled in a non-inferiority cluster randomized controlled trial. Alcohol use and risky drinking in the past 12 months were assessed using the Alcohol Use Disorders Identification Test (AUDIT-C) tool. Log-binomial regression models were applied to identify factors associated with alcohol use and risky alcohol use. Overall, 31.4% of participants reported current alcohol use ( n = 242). Among these individuals, 45.5% ( n = 110) engaged in risky alcohol use (14.2% among all participants). About a quarter (23.2%) were classified as engaging in heavy episodic drinking (HED). In multivariable models, older adults (RR = 0.27; 95%CI: 0.13–0.54) and males (RR = 0.68; 95%CI: 0.46–1.01) had a lower risk of risky alcohol use. Individuals who had disclosed their status to their partners were more likely to report risky alcohol use compared to those who had not disclosed (RR = 1.33; 95%CI:1.00–1.78). These findings indicate that alcohol use is common among adults living with HIV, with half of current drinkers engaging in risky consumption patterns, including HED. Risky alcohol use was more prevalent among younger adults and women. These results underscore the need for targeted interventions addressing risky alcohol use within primary HIV care settings, particularly for young adults and women.
- Open Access
- 28 February 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (5) , 103189
Surveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis
- 28 February 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (5) , 103189
Open AccessSurveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis
- Open Access
Impact of violence on HIV outcomes among female sex workers: A global systematic review and meta-analysis
Background: Female sex workers (FSW) are a key population for HIV prevention and care. Increasing evidence suggests that social and structural barriers are key drivers of HIV transmission. This global systematic review assesses whether experiencing violence is associated with worse HIV outcomes among FSW. Methods and Findings: We searched MEDLINE, Embase, and PsycINFO databases for studies published from January 1 st , 2010 to February 10 th , 2025 assessing the impact of violence on HIV outcomes among FSW, without restriction to language and study design. Some studies had multiple estimates due to reporting on multiple outcomes or exposures of interest. We pooled data from eligible studies using multi-level random-effects meta-analyses to quantify associations between recent (past year) or lifetime exposure to violence (physical, sexual, emotional/psychological and/or financial) and HIV outcomes (prevalent and incident HIV infection, HIV testing, ART use, ART adherence, and viral suppression) among FSW. We preferentially used adjusted estimates over unadjusted estimates if both were available. We included 91 studies with 221 estimates, comprising 179,727 FSWs in 37 countries. We found higher odds of prevalent HIV infection among FSWs with recent (pooled odds ratio (pOR):1.33; 95%CI:1.17–1.51; I 2 :64%; n=73 estimates) and lifetime (pOR:1.36; 95%CI:1.24–1.49; I 2 :38%; n=67) experiences of violence. Recently experiencing violence was associated with reduced odds of ART use (pOR:0.78; 95%CI:0.64–0.94; I 2 :8%; n=17). Lifetime exposure to violence was associated with reduced odds of viral suppression (pOR:0.88; 95%CI:0.79–0.98; I 2 :20%; n=6). There was no evidence of associations between violence and HIV incidence, HIV testing and ART adherence. Conclusions: Experiencing violence may increase HIV transmission risk and worsen HIV treatment outcomes among FSW. HIV interventions for FSWs must address violence as a structural determinant of HIV.
Open AccessImpact of violence on HIV outcomes among female sex workers: A global systematic review and meta-analysis
Background: Female sex workers (FSW) are a key population for HIV prevention and care. Increasing evidence suggests that social and structural barriers are key drivers of HIV transmission. This global systematic review assesses whether experiencing violence is associated with worse HIV outcomes among FSW. Methods and Findings: We searched MEDLINE, Embase, and PsycINFO databases for studies published from January 1 st , 2010 to February 10 th , 2025 assessing the impact of violence on HIV outcomes among FSW, without restriction to language and study design. Some studies had multiple estimates due to reporting on multiple outcomes or exposures of interest. We pooled data from eligible studies using multi-level random-effects meta-analyses to quantify associations between recent (past year) or lifetime exposure to violence (physical, sexual, emotional/psychological and/or financial) and HIV outcomes (prevalent and incident HIV infection, HIV testing, ART use, ART adherence, and viral suppression) among FSW. We preferentially used adjusted estimates over unadjusted estimates if both were available. We included 91 studies with 221 estimates, comprising 179,727 FSWs in 37 countries. We found higher odds of prevalent HIV infection among FSWs with recent (pooled odds ratio (pOR):1.33; 95%CI:1.17–1.51; I 2 :64%; n=73 estimates) and lifetime (pOR:1.36; 95%CI:1.24–1.49; I 2 :38%; n=67) experiences of violence. Recently experiencing violence was associated with reduced odds of ART use (pOR:0.78; 95%CI:0.64–0.94; I 2 :8%; n=17). Lifetime exposure to violence was associated with reduced odds of viral suppression (pOR:0.88; 95%CI:0.79–0.98; I 2 :20%; n=6). There was no evidence of associations between violence and HIV incidence, HIV testing and ART adherence. Conclusions: Experiencing violence may increase HIV transmission risk and worsen HIV treatment outcomes among FSW. HIV interventions for FSWs must address violence as a structural determinant of HIV.